CONGLETON JON (Chief Executive Officer) sold 12.4% of their position (75K shares) of MINERALYS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.91M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/2/2026ACC: 0001933414-26-000121
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-75K
Net shares
Net seller
$1.91M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
75K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−75K
Price / share
$25.46
Trade value
$1.91M
% of position
12.4%
9/30/2026
603.62K→528.62K
Total
Net shares
−75K
Net value
-$1.91M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2026 | S · Sale | −75K | $25.46 | $1.91M | 12.4% | 603.62K | 528.62K |
| Total | −75K | -$1.91M | ||||||
Derivative Transactions0
No derivative transactions reported